| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cost of Revenue | $501K | — | -30.8% |
| R&D Expense | $282K | — | -16.1% |
| SG&A Expense | $2.9M | — | +22.9% |
| Operating Income | -$4.1M | — | +52.3% |
| Pre-tax Income | -$4.0M | — | +52.5% |
| Net Income | -$4.0M | — | +52.4% |
| EPS (Basic) | -$1.22 | — | -18.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $6.8M | -36.9% | +328.9% |
| Inventory | $244K | +0.0% | -0.4% |
| Current Assets | $11.1M | -17.2% | +400.0% |
| Total Assets | $17.1M | -13.1% | -5.2% |
| Current Liabilities | $3.6M | -18.3% | -49.5% |
| Total Liabilities | $4.0M | -19.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.8M | — | -39.6% |
| Capital Expenditures | $0 | — | -100.0% |
| Investing Cash Flow | -$2.0M | — | -433.3% |
| Financing Cash Flow | $1.9M | — | +190.0% |
| Free Cash Flow | -$3.8M | — | -26.4% |
| -53.2% |
| Stockholders' Equity | $13.1M | -11.1% | +37.7% |